Swine Flu - Mobile News

Gilead And Roche Ready Swine Flu Vaccines

added 45 weeks ago from bizjournals.com

[bizjournals.com]
Gilead, Roche ready with swine flu vaccine
As global fears of swine flu rise, there has been one surprising beneficiary -- investors in Foster City-based Gilead Sciences Inc. and U.K. drugmaker GlaxoSmithKline.

Shares of both companies are trading up because they are behind flu treatments that are currently being used to combat the disease -- Gilead (NASDAQ: GILD) is the co-developer of Tamiflu, and GlaxoSmithKline (NYSE: GSK) controls Relenza. The U.S. government released a quarter of its stockpiles of the drugs after declaring a national health emergency with at least 20 cases of swine flu confirmed.
Read...


Related Swine Flu News

Search: